Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retina Vascular Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04271709
What this trial is testing

Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

Who this might be right for
GlaucomaVision Impairment and BlindnessCataract+2 more
Columbia University 749
Post-approval studies (Phase 4)Ended earlyNCT04707625
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment

Who this might be right for
Retinal Vein Occlusion
Wake Forest University Health Sciences 17
Not applicableLooking for participantsNCT07359664
What this trial is testing

OCTA in Cardiovascular Disease and Healthy Controls

Who this might be right for
Patients With Cardiovascular DiseaseHealthy Participants
University of Erlangen-Nürnberg Medical School 64
Post-approval studies (Phase 4)Study completedNCT00504959
What this trial is testing

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization (CNV)Secondary to Age-related Macular Degeneration (AMD)
Novartis 234
Not applicableWithdrawnNCT03603990
What this trial is testing

Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema

Who this might be right for
EdemaMacular EdemaDiabetic Retinopathy+3 more
Fondation Ophtalmologique Adolphe de Rothschild
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Not applicableUnknownNCT05534308
What this trial is testing

Effect of Intraoperative Taping on the Control of Edema Resulting From Stripping

Who this might be right for
EdemaVarices; Cord
University of Sao Paulo 60
Not applicableLooking for participantsNCT06416371
What this trial is testing

Retinal Vessel Leakage in Cerebral Small Vessel Disease

Who this might be right for
Cerebral Small Vessel DiseasesLacunar StrokeVascular Dementia
University of Edinburgh 40
Not applicableStudy completedNCT00001733
What this trial is testing

Screening for Studies on Retinovascular Diseases

Who this might be right for
Diabetic RetinopathyMacular DegenerationPathologic Neovascularization+1 more
National Eye Institute (NEI) 2,000
Large-scale testing (Phase 3)Study completedNCT01846299
What this trial is testing

To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema

Who this might be right for
Macular Edema (ME)
Novartis Pharmaceuticals 181
Early research (Phase 1)Ended earlyNCT01225146
What this trial is testing

Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)

Who this might be right for
IschemiaRetinal Vein OcclusionPathologic Processes+2 more
David M. Brown, M.D. 8
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableLooking for participantsNCT06797752
What this trial is testing

Effect of the Stellate Ganglion Block on the Retinal Microcirculation

Who this might be right for
OCTASevere Brain InjurySubarachnoid Hemorrhage+1 more
University of Texas Southwestern Medical Center 50
Not applicableUnknownNCT03631108
What this trial is testing

Feasibility Study and Preliminary Application Study on Iris OCTA

Who this might be right for
ConjunctivitisGlaucomaMyopia+4 more
Shanghai Eye Disease Prevention and Treatment Center 4,000
Post-approval studies (Phase 4)Study completedNCT01223612
What this trial is testing

Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation

Who this might be right for
Diabetic Retinopathy
Moorfields Eye Hospital NHS Foundation Trust 37
Testing effectiveness (Phase 2)Study completedNCT01295775
What this trial is testing

Diabetic Retinopathy Sulodexide Study

Who this might be right for
Diabetic Retinopathy
Ajou University School of Medicine 127
Not applicableStudy completedNCT05135195
What this trial is testing

A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training

Who this might be right for
Visual ImpairmentAge-Related Macular DegenerationDiabetic Retinopathy+1 more
NYU Langone Health 98
Large-scale testing (Phase 3)Study completedNCT01908816
What this trial is testing

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

Who this might be right for
Choroidal NeovascularizationMacular EdemaGlaucoma, Neovascular+1 more
Novartis Pharmaceuticals 270
Not applicableLooking for participantsNCT06881368
What this trial is testing

Phenotypic and Etiological Characterization of Susac Syndrome

Who this might be right for
Susac Syndrome
Assistance Publique - Hôpitaux de Paris 180
Testing effectiveness (Phase 2)Study completedNCT00775411
What this trial is testing

Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Maculopathy
Allergan 44
Next Page